Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemant Kumar Bid

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Plos One|November 30, 2017
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlatesGonzalo Lopez, Danielle Braggio, Abeba Zewdu, et al.
International Journal of Cancer|June 25, 2017
Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinomaKristin Bixel, Uksha Saini, Hemant Kumar Bid, et al.
NPJ Precision Oncology|January 12, 2022
Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcomaSafiya Khurshid, Matias Montes, Daniel F Comiskey, et al.
Bioorganic & Medicinal Chemistry|May 9, 2009
Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agentsRavi Shankar, Bandana Chakravarti, Uma Sharan Singh, et al.
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Plos One|November 30, 2017
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlatesGonzalo Lopez, Danielle Braggio, Abeba Zewdu, et al.
International Journal of Cancer|June 25, 2017
Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinomaKristin Bixel, Uksha Saini, Hemant Kumar Bid, et al.
NPJ Precision Oncology|January 12, 2022
Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcomaSafiya Khurshid, Matias Montes, Daniel F Comiskey, et al.
Bioorganic & Medicinal Chemistry|May 9, 2009
Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agentsRavi Shankar, Bandana Chakravarti, Uma Sharan Singh, et al.
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
Pageof 4